MS. MELISSA RHODES, RN
Nursing at Savannah Rd, Lewes, DE
License number
Delaware 172363
Category
Nursing
Type
Registered Nurse
Address
Address
2
424 Savannah Rd, Lewes, DE 19958
7474 Creedmoor Rd Pmb #102, Raleigh, NC 27613
7474 Creedmoor Rd Pmb #102, Raleigh, NC 27613
Phone
(302) 645-3300
Professional information
Melissa Rhodes
Position:
Director, Safety Assessment Projects at GlaxoSmithKline
Location:
Raleigh-Durham, North Carolina Area
Industry:
Pharmaceuticals
Work:
GlaxoSmithKline
since Nov 2011
-
Director, Safety Assessment Projects
GlaxoSmithKline
Oct 2009 - Nov 2011
-
Senior Manager, Safety Assessment Project Development
GlaxoSmithKline
Mar 2006 - Oct 2009
-
Toxicologist/Manager, Safety Assessment Projects
Erimos Pharmaceuticals
Oct 2005 - Mar 2006
-
Manager, Safety Assessment & DMPK
Erimos Pharmaceuticals
Aug 2004 - Oct 2005
-
Toxicologist
National Toxicology Program, National Institute of Environmental Health Sciences
Dec 2003 - Aug 2004
-
Research Fellow
Education:
Duke University 1999 - 2003
North Carolina State University 1995 - 1999
North Carolina State University 1995 - 1999
Rn At Rex Healthcare
Position:
RN at Rex Healthcare
Location:
Raleigh-Durham, North Carolina Area
Industry:
Hospital & Health Care
Work:
Rex Healthcare
-
RN
Melissa Rhodes
Location:
Raleigh-Durham, North Carolina Area
Industry:
Hospital & Health Care
Methods And Compositions For Treatment Of Intraepithelial Neoplasia
US Patent:
2008000, Jan 3, 2008
Filed:
Jul 19, 2005
Appl. No.:
11/572349
Inventors:
Neil Frazer - Cary NC, US
Jonathan Heller - Raleigh NC, US
Rocio Lopez - Durham NC, US
Melissa Rhodes - Raleigh NC, US
Ru Chih Huang - Baltimore MD, US
Richard Dalby - Timonium MD, US
Niharika Khanna - Ellicott City MD, US
Jonathan Heller - Raleigh NC, US
Rocio Lopez - Durham NC, US
Melissa Rhodes - Raleigh NC, US
Ru Chih Huang - Baltimore MD, US
Richard Dalby - Timonium MD, US
Niharika Khanna - Ellicott City MD, US
Assignee:
ERIMOS PHARMACEUTICALS LLC - Houston TX
JOHNS HOPKINS UNIVERSITY - Baltimore MD
UNIVERSITY OF MARYLAND, BALTIMORE - Baltimore MD
JOHNS HOPKINS UNIVERSITY - Baltimore MD
UNIVERSITY OF MARYLAND, BALTIMORE - Baltimore MD
International Classification:
A61K 31/015, A61K 31/195, A61P 43/00
US Classification:
514567000, 514764000
Abstract:
The present invention provides for compositions, kits and methods for treatment of intraepithelial neoplasia, where the compositions include catecholic butanes, which include NDGA derivatives.
Formulations For Injection Of Catecholic Butanes, Including Ndga Compounds, Into Animals
US Patent:
2008009, Apr 24, 2008
Filed:
Jan 27, 2006
Appl. No.:
11/814880
Inventors:
Rocio Lopez - Raleigh NC, US
Jessica Blomberg - Raleigh NC, US
Melissa Rhodes - Raleigh NC, US
Jonathan Heller - San Francisco CA, US
Jessica Blomberg - Raleigh NC, US
Melissa Rhodes - Raleigh NC, US
Jonathan Heller - San Francisco CA, US
Assignee:
ERIMOS PHARMACEUTICALS LLC - Raleigh NC
International Classification:
A61K 31/015, A61K 47/00, A61K 31/05, A61K 31/195, A61P 9/00, A61P 17/00, A61P 1/00, A61P 25/00
US Classification:
514567000, 514773000, 514781000, 514764000, 514734000, 514568000
Abstract:
The present invention provides for a composition, kit and method for treatment of diseases, where the composition contains at least one catecholic butane, including NDGA compounds and derivatives, together with a pharmaceutically acceptable carrier that may include solubilizing agents or excipients, where the composition is suitable for injection into animals.
Oral Formulations For Delivery Of Catecholic Butanes Including Ndga Compounds
US Patent:
2009002, Jan 22, 2009
Filed:
Jan 27, 2006
Appl. No.:
11/814838
Inventors:
Rocio Alejandra Lopez - Raleigh NC, US
Jessica Andrea LoDuca Blomberg - Raleigh NC, US
Melissa Claire Rhodes - Raleigh NC, US
Jonathan Daniel Heller - San Francisco CA, US
Amanda Beth Goodman - Wake Forest NC, US
Jessica Andrea LoDuca Blomberg - Raleigh NC, US
Melissa Claire Rhodes - Raleigh NC, US
Jonathan Daniel Heller - San Francisco CA, US
Amanda Beth Goodman - Wake Forest NC, US
Assignee:
ERIMOS PHARMACEUTICALS LLC - Raleigh NC
International Classification:
A61K 9/14, A61K 31/24
US Classification:
424486, 424488, 514536
Abstract:
The present invention provides for compositions, kits and methods for treatment of diseases, where the compositions contain catecholic butanes, including NDGA compounds, such as NDGA derivatives, for example tetra-O-methyl NDGA. The present invention also provides for solubilizing agents and excipients that are suitable for administration of the present compounds into animals via an oral route, whether in a liquid, semi-solid or solid form.